Apyx Medical Corporation

NasdaqGS:APYX Stock Report

Market Cap: US$40.2m

Apyx Medical Past Earnings Performance

Past criteria checks 0/6

Apyx Medical's earnings have been declining at an average annual rate of -7.4%, while the Medical Equipment industry saw earnings growing at 11.4% annually. Revenues have been growing at an average rate of 16.1% per year.

Key information

-7.4%

Earnings growth rate

-6.9%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate16.1%
Return on equity-190.8%
Net Margin-57.9%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Is There An Opportunity With Apyx Medical Corporation's (NASDAQ:APYX) 41% Undervaluation?

Sep 14
Is There An Opportunity With Apyx Medical Corporation's (NASDAQ:APYX) 41% Undervaluation?

Apyx Medical Corporation (NASDAQ:APYX) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Aug 07
Apyx Medical Corporation (NASDAQ:APYX) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed

Aug 01
We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed

Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?

Jun 19
Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?

Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive

Apr 18
Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive

Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates

Mar 26
Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates

Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)

Feb 16
Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)

Is Apyx Medical (NASDAQ:APYX) A Risky Investment?

Sep 14
Is Apyx Medical (NASDAQ:APYX) A Risky Investment?

Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?

Jun 07
Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?

Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically

Mar 21
Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically

Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation

Dec 14
Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation

We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate

Aug 30
We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate

Apyx Medical GAAP EPS of -$0.16 beats by $0.03, revenue of $10.3M misses by $0.26M

Aug 11

Apyx Medical gets FDA nod for Renuvion's use in improving loose skin on neck, chin

Jul 18

Revenue & Expenses Breakdown

How Apyx Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:APYX Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2449-28485
31 Mar 2450-23485
31 Dec 2352-19495
30 Sep 2350-15485
30 Jun 2347-16485
31 Mar 2344-21475
31 Dec 2245-23485
30 Sep 2249-19484
30 Jun 2251-18484
31 Mar 2252-16474
31 Dec 2149-15444
30 Sep 2143-15404
30 Jun 2138-14374
31 Mar 2131-15344
31 Dec 2028-12344
30 Sep 2025-16344
30 Jun 2025-16354
31 Mar 2028-16364
31 Dec 1928-20354
30 Sep 1926-18343
30 Jun 1922-15293
31 Mar 1919-14263
31 Dec 1817-11223
30 Sep 1814-10182
30 Jun 1813-12172
31 Mar 185-15172
31 Dec 1710-14172
30 Sep 17-12-19151
30 Jun 17-4-17151
31 Mar 1737-4203
31 Dec 169-12151
30 Sep 1635-5183
30 Jun 1633-5182
31 Mar 1631-6182
31 Dec 15308172
30 Sep 15294172
30 Jun 15283162
31 Mar 15274162
31 Dec 1428-18131
30 Sep 1426-18141
30 Jun 1425-15111
31 Mar 1424-16111
31 Dec 1324-7121
30 Sep 1324-2101

Quality Earnings: APYX is currently unprofitable.

Growing Profit Margin: APYX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: APYX is unprofitable, and losses have increased over the past 5 years at a rate of 7.4% per year.

Accelerating Growth: Unable to compare APYX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: APYX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.2%).


Return on Equity

High ROE: APYX has a negative Return on Equity (-190.8%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies